Cas 1010446-43-1,(S)-3-(pyridin-4-ylamino)-pyrrolidine-1-carboxylic acid tert-butyl ester

1010446-43-1

Post Buying Request

Basic information

Product Name: (S)-3-(pyridin-4-ylamino)-pyrrolidine-1-carboxylic acid tert-butyl ester
Synonyms:
CAS NO:1010446-43-1
Molecular Formula:
Molecular Weight: 263.34
EINECS: N/A
Product Categories: N/A
Mol File: 1010446-43-1.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (S)-3-(pyridin-4-ylamino)-pyrrolidine-1-carboxylic acid tert-butyl ester(CAS DataBase Reference)
NIST Chemistry Reference: (S)-3-(pyridin-4-ylamino)-pyrrolidine-1-carboxylic acid tert-butyl ester(1010446-43-1)
EPA Substance Registry System: (S)-3-(pyridin-4-ylamino)-pyrrolidine-1-carboxylic acid tert-butyl ester(1010446-43-1)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1010446-43-1(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1010446-43-1 Suppliers

Recommended suppliersmore

1010446-43-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1010446-43-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,1,0,4,4 and 6 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1010446-43:
(9*1)+(8*0)+(7*1)+(6*0)+(5*4)+(4*4)+(3*6)+(2*4)+(1*3)=81
81 % 10 = 1
So 1010446-43-1 is a valid CAS Registry Number.

1010446-43-1Upstream product

1010446-43-1Downstream Products

1010446-43-1Relevant articles and documents

SUBSTITUTED BENZIMIDAZOLONE DERIVATIVES, MEDICAMENTS COMPRISING THEM AND THEIR USE

-

Page/Page column 100, (2008/06/13)

The present invention relates to novel benzimidazolone derivatives of the general formula (I) in which the substituents R1, R2, R3, A1, A2, and B are as defined in claim 1, medicaments comprising these, and the use thereof for the prophylaxis and/or treatment of vasopressin-dependent diseases.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1010446-43-1